Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights| (NASDAQ: DNLI) | Delayed: 22.28 -0.52 (2.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.80 | 52 Week High | $ | |||
| Open | $22.32 | 52 Week Low | $ | |||
| Day High | $22.48 | P/E | N/A | |||
| Day Low | $22.15 | EPS | $ | |||
| Volume | 799,634 | |||||

